Outlook Therapeutics (OTLK) Enterprise Value (2016 - 2026)
Outlook Therapeutics (OTLK) recorded Enterprise Value of $206.18 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 239.9% from $60.67 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Enterprise Value (2016 - 2026) Analysis & Trends
On a TTM basis, Outlook Therapeutics' Enterprise Value came in at $181.67 million as of Jun 30, 2026, up 459.3% year-over-year; for FY2025 (ended Sep 30, 2025), it was $28.8 million, down 65.8% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
- Across earlier fiscal years, Enterprise Value came in at $84.12 million in FY2024 (+146.5%), $34.12 million in FY2023 (-86.9%), $259.92 million in FY2022 (-29.5%) and $368.44 million in FY2021 (+828.0%).
- The fiscal Q3 2026 figure is the highest quarterly Enterprise Value since fiscal Q3 2023.
- On a year-over-year basis, Enterprise Value rose in three of the last eight quarters, with growth averaging 23.7%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 828.0% in fiscal Q4 2021, against a decline of 86.9% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $9.44 million (Q2 2026), $93.32 million (Q1 2026) and $28.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.18 Mn |
| Mar 31, 2026 | 9.44 Mn |
| Dec 31, 2025 | 93.32 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Jun 30, 2025 | 60.67 Mn |
| Mar 31, 2025 | 32.59 Mn |
| Dec 31, 2024 | 41.37 Mn |
| Sep 30, 2024 | 84.12 Mn |
| Jun 30, 2024 | 140.71 Mn |
| Mar 31, 2024 | 123.16 Mn |
| Dec 31, 2023 | 92.18 Mn |
| Sep 30, 2023 | 34.12 Mn |
| Jun 30, 2023 | 416.44 Mn |
| Mar 31, 2023 | 236.14 Mn |
| Dec 31, 2022 | 224.86 Mn |
| Sep 30, 2022 | 259.92 Mn |
| Jun 30, 2022 | 204.44 Mn |
| Mar 31, 2022 | 343.49 Mn |
| Dec 31, 2021 | 234.84 Mn |
| Sep 30, 2021 | 368.44 Mn |
API Access
Outlook Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();